On 29.03.2023 the extension of the approval periods of 37 substances was published in the Official Journal
24th April 2023
Extension 37 approvals published
24April
11th March 2022
Extension 39 substances published
11March
On 07.03.2022 a Regulation was published extending the approval periods of 39 substances.
11th January 2022
Agenda SCoPAFF Legislation 27-28 January 2022 published
11January
On 10.01.2022 the agenda for the SCoPAFF Legislation meeting of 27-28.01.2022 was published on the DG SANTE website.
19th August 2021
EFSA position on Codex issues
19August
EFSA published their scientific support for the EU, for the 52nd session of the CCPR (Codex meeting).
27th April 2021
SCoPAFF Legislation (Jan.2021) report published
27April
DG SANTE published the summary report of the 25-26 January meeting.
14th April 2021
Extension 41 substances published
14April
On 07.04.2021 the extension of the approval periods of 41 substances was published in the Official Journal.
6th January 2021
SCoPAFF Legislation agenda January 2021 published
06January
On 06.01.2021, the agenda for the upcoming SCoPAFF Legislation meeting of 25-26.01.2021 was published.
8th December 2020
RoQ 08.12.2020
08December
amidosulfuron, clomazone, daminozide , deltamethrin, deltamethrin, emamectin benzoate, fluoxastrobin, folpet, fosetyl, gibberellic acid, gibberellin, lenacil, mepiquat chloride, meptyldinocap...
12th October 2020
RoQ 12.10.2020
12October
S-metolachlor, fluoxastrobin, metconazole, triflusulfuron, metribuzin, propiconazole, dithianon, Purpureocillium lilacinum strain PL 11
2nd September 2020
RoQ 02.09.2020
02September
49 changes in the deadlines for EFSA comments on JMPR proposed Codex MRLs and toxicological reference vallues evaluated by JMPR in 2019. Deadlines were changed from 31.07.2020 to 31.07 2021
20th March 2020
Regulation extension 46 substances
20March
On 20.03.2020 Regulation 2020/421 was published, extending the approval periods of 46 substances.
6th March 2020
SCoPAFF Legislation report 18 February published, extensions
06March
DG SANTE published the report on the extra SCoPAFF meeting voting on the extension of 34 substances, excluding the extension of epoxiconazole.
3rd April 2019
New EFSA peer review meetings scheduled
03April
EFSA published the agenda for a new series of Peer Review expert meetings, in the period May-July 2019.
26th February 2019
PAFF Legislation meeting minutes Dec. 2018 published
26February
On 25.02.2019 DG SANTE published the minutes/report of the PAFF Legislation meeting of 12-13 December 2018.
5th February 2019
Regulation extending approvals AIR 3.4, 3.8 and 4.1
05February
On 05 February 2019, the extension of 42 substances was published in the Official Journal.
3rd December 2018
PAFF Legislation agenda published
03December
DG SANTE published the agenda for the PAFF Legislation meeting on 12-13 December 2018.
1st August 2018
Metconazole Public Consultation
01August
On 01.08.2018 EFSA initiated the public consultation on the RAR for metconazole drafted by RMS Belgium on the basis of a renewal dossier submitted by BASF.
5th July 2018
AIR 3 Working Document SANCO/2012/11284, revision 21
05July
A new revision of this Working Document was published: Rev. 21 of June 2018 shows the following changes in comparison with Rev. 20: AIR 3.1 substances: integration of Reg. 2018/917, extension from 31...
11th April 2018
Regulation extension AIR 3.4 & 3.8
11April
With Regulation 2018/554 of 28.03.2018, published in the Official Journal L88 of 04.04.2018, 22 substances received an extension until 30.04.2019: AIR 3.4: thiram, ziram, quinoxyfen...